|
Jul 25
|
Carmila: Closing of the Acquisition of a Stake of 7% of Galimmo SCA from Capimmo
|
|
Jul 24
|
Carmila: Launch of a Share Buyback Program for €10 Million
|
|
Jul 24
|
Carmila: 2024 Half-Year Financial Report Available
|
|
Jul 24
|
Carmila: 2024 Half-Year Results
|
|
Dec 5
|
Carmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiers
|
|
Nov 10
|
Carmila: Termination of Liquidity Contract With BNP Paribas Arbitrage and New Liquidity Contract With Kepler Cheuvreux
|
|
Nov 9
|
CARMILA: Information Concerning the Total Number of Voting Rights and Share
|
|
Nov 9
|
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
|